<DOC>
	<DOCNO>NCT00377858</DOCNO>
	<brief_summary>A study patient type 2 diabetes inadequate glycemic control two oral antihyperglycemic agent compare add insulin lispro mid mixture oral antihyperglycemic agent add insulin glargine oral antihyperglycemic agent .</brief_summary>
	<brief_title>Comparison Two Approaches Insulin Therapy Patients With Type 2 Diabetes ( IOOX )</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<mesh_term>Insulin , Globin Zinc</mesh_term>
	<mesh_term>Insulin</mesh_term>
	<mesh_term>Insulin Lispro</mesh_term>
	<mesh_term>Insulin Glargine</mesh_term>
	<criteria>Have type 2 diabetes Have receive oral antihyperglycemic medication ( OAM ) without insulin include least two follow maximally tolerate dos , AND meet minimum dose criterion show : Metformin 1500 mg/day , Sulfonylurea 1/2 maximum daily dose , accord package insert , Thiazolidinedione ( TZD ) 30 mg/day pioglitazone 4 mg/day rosiglitazone . The OAMs also must use accordance product label Have hemoglobin A1c great equal 7.5 % less equal 12.0 % . Are take TZD dose great indicated combination insulin accord TZD label . Are take glucoselowering agent mention Inclusion Criterion . Have take acarbose , miglitol , pramlintide , exenatide , repaglinide , nateglinide past 6 week total 30 day last 24 week . Have body mass index great 40 kg/m2 . Have one episode severe hypoglycemia last24 week Are pregnant , intend pregnant course study breastfeed Have clinically significant cardiac , renal , hematologic , oncologic , hepatic disease</criteria>
	<gender>All</gender>
	<minimum_age>30 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>December 2009</verification_date>
	<keyword>diabetes</keyword>
	<keyword>type 2</keyword>
</DOC>